GRCE
Price:
$3.28
Market Cap:
$46.36M
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Industry
Biotechnology
IPO Date
2012-02-07
Stock Exchange
NASDAQ
Ticker
GRCE
According to Grace Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.19. This represents a change of 283.31% compared to the average of -1.61 of the last 4 quarters.
The mean historical PE Ratio of Grace Therapeutics, Inc. over the last ten years is -0.86. The current -6.19 PE Ratio has changed 71.54% with respect to the historical average. Over the past ten years (40 quarters), GRCE's PE Ratio was at its highest in in the March 2025 quarter at 12.29. The PE Ratio was at its lowest in in the September 2025 quarter at -12.65.
Average
-0.86
Median
-0.45
Minimum
-2.88
Maximum
-0.08
Discovering the peaks and valleys of Grace Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual PE Ratio = -0.08
Minimum Annual Increase = -71.98%
Minimum Annual PE Ratio = -2.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.88 | 65.40% |
| 2024 | -1.74 | 230.15% |
| 2023 | -0.53 | -71.98% |
| 2022 | -1.88 | 397.98% |
| 2021 | -0.38 | 81.82% |
| 2020 | -0.21 | 80.10% |
| 2019 | -0.12 | 35.92% |
| 2018 | -0.08 | -56.25% |
| 2016 | -0.19 | -69.14% |
| 2015 | -0.63 | 1.02% |
The current PE Ratio of Grace Therapeutics, Inc. (GRCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.72
5-year avg
-1.48
10-year avg
-0.86
Grace Therapeutics, Inc.’s PE Ratio is less than LAVA Therapeutics N.V. (-1.65), less than Tvardi Therapeutics, Inc. (-2.81), less than Actinium Pharmaceuticals, Inc. (-1.31), less than PDS Biotechnology Corporation (-1.20), greater than CalciMedica, Inc. (-2987.83), less than Xilio Therapeutics, Inc. (-2.53), less than Lantern Pharma Inc. (-2.11), less than OnKure Therapeutics, Inc. (-5.35), less than RenovoRx, Inc. (-3.26), greater than ABVC BioPharma, Inc. (-14.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.65 | $45.77M | |
| -2.81 | $39.21M | |
| -1.31 | $45.23M | |
| -1.20 | $43.78M | |
| -2987.83 | $65.85M | |
| -2.53 | $38.90M | |
| -2.11 | $42.17M | |
| -5.35 | $35.63M | |
| -3.26 | $34.82M | |
| -14.15 | $36.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grace Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Grace Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Grace Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Grace Therapeutics, Inc. (GRCE)?
What is the highest PE Ratio for Grace Therapeutics, Inc. (GRCE)?
What is the 3-year average PE Ratio for Grace Therapeutics, Inc. (GRCE)?
What is the 5-year average PE Ratio for Grace Therapeutics, Inc. (GRCE)?
How does the current PE Ratio for Grace Therapeutics, Inc. (GRCE) compare to its historical average?